|
|
| (4 intermediate revisions by the same user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| |
| {{Congenital adrenal hyperplasia}}
| |
|
| |
|
| {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}
| |
|
| |
| ==Overview==
| |
|
| |
| == Epidemiology and Demographics ==
| |
| The classic type affects approximately 1 in 16,000 live births.2 NCCAH is one of the most common autosomal recessive disorders in humans and affects approximately 1 in 1000 individuals.3 The second most common form of CAH, 11b-hydroxylase deficiency (11-OHD), occurs in 1 in 100,000 live births in the general population and accounts for approximately 5% of cases.4 Other less common forms of CAH include 3b-hydroxysteroid dehydrogenase type 2 deficiency, 17a-hydroxylase deficiency that is more commonly seen in Brazil and Mennonite descendants from Dutch Friesland; congenital lipoid adrenal hyperplasia that is more commonly seen in the Japanese and Korean populations; side-chain cleavage (SCC) enzyme deficiency that is most commonly found in Turkey; and cytochrome P450 oxidoreductase deficiency, the only variant that can manifest with skeletal malformation
| |
|
| |
| CAH ART
| |
|
| |
| ==References==
| |
| {{Reflist|2}}
| |
| [[Category:Disease]]
| |
| [[Category:Pediatrics]]
| |
| [[Category:Endocrinology]]
| |
| [[Category:Genetic disorders]]
| |
| [[Category:Intersexuality]]
| |
|
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |